Adjuvant Chemotherapy in Patients With Resected Pancreatic Cancer After Neoadjuvant FOLFIRINOX
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Evaluation of Adjuvant Chemotherapy in Patients With Resected Pancreatic Cancer After Neoadjuvant FOLFIRINOX Treatment
JAMA Oncol 2020 Sep 10;[EPub Ahead of Print], S van Roessel, E van Veldhuisen, S Klompmaker, QP Janssen, M Abu Hilal, A Alseidi, A Balduzzi, G Balzano, C Bassi, F Berrevoet, M Bonds, OR Busch, G Butturini, M Del Chiaro, KC Conlon, M Falconi, I Frigerio, GK Fusai, J Gagnière, O Griffin, T Hackert, A Halimi, U Klaiber, KJ Labori, G Malleo, MV Marino, MB Mortensen, A Nikov, M Lesurtel, T Keck, J Kleeff, R Pandé, P Pfeiffer, D Pietrasz, KJ Roberts, A Sa Cunha, R Salvia, O Strobel, T Tarvainen, PM Bossuyt, HWM van Laarhoven, JW Wilmink, B Groot Koerkamp, MG BesselinkFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.